Continuous analyte monitoring system

Abstract

The utility model discloses a continuous analyte monitoring system which is used for solving the problems that in the prior art, the connection steps between a display device and an electronic unit are tedious, and the possibility that the display device and the electronic unit can be successfully connected through multiple times of operation exists between the display device and the electronic unit. The system comprises: an analyte sensor for acquiring analyte parameters; an electronics module coupled to the analyte sensor to acquire analyte parameters; the implanting device is used for implanting the analyte sensor into the tissue under the skin, and the implanting device is provided with a near field communication tag; the display device is used for being wirelessly connected with the electronic module to display analyte data, the analyte data is obtained based on the analyte parameters, and the display device comprises a near field communication module; wireless connection is established between the display device and the electronic module through a near field communication technology.

Description

[0001] The present application has priority to the utility model patent application No. 202520654855.X, filed on April 8, 2025 in China Patent Office, and entitled “A continuous analyte monitoring system”. TECHNICAL FIELD

[0002] The present application relates to the technical field of analyte monitoring, and in particular to a continuous analyte monitoring system. BACKGROUND

[0003] It is essential to detect various analytes in the body of an individual for monitoring the health condition of the individual, and a deviation from a normal analyte level usually indicates a potential physiological condition, such as a metabolic condition, a disease, etc. Periodic ex vivo analyte monitoring using extracted body fluid is sufficient to observe the physiological condition of many individuals. However, ex vivo analyte monitoring has a limited number of detection values, and there is a possibility that a patient is caused irreversible damage due to missing a best treatment opportunity because of missing key measurement data. In addition, for an individual with a severe analyte disorder and / or an individual with a rapid fluctuation of analyte level, it is necessary to extract body fluid more frequently for monitoring, which will bring inconvenience and pain to the patient.

[0004] In many cases, a subcutaneous, interstitial or skin analyte sensor can provide sufficient measurement accuracy while minimizing user discomfort, and continuous analyte monitoring using an analyte monitoring sensor implanted in the body is a relatively ideal monitoring method. Generally, an implanted device is used to implant an analyte monitoring sensor into the body of an individual, the sensor reacts with the body fluid of the implanted individual to generate an electrical signal, an electronic unit is electrically connected to the sensor to obtain the electrical signal, and a display device is wirelessly connected to the electronic unit to display analyte data obtained based on the electrical signal, so as to realize continuous monitoring of the analyte concentration.

[0005] In the existing detection system, the connection step between the display device and the electronic unit is relatively cumbersome, and there is a possibility that multiple operations are required to successfully connect the two. UTILITY MODEL CONTENT

[0006] The present application provides a continuous analyte monitoring system capable of simplifying the connection step between the display device and the electronic module and improving the probability of successful connection with one operation.

[0007] In one aspect, the present application provides a continuous analyte monitoring system, comprising:

[0008] an analyte sensor configured to obtain an analyte parameter;

[0009] an electronic module coupled to the analyte sensor to obtain the analyte parameter;

[0010] an implant device configured to implant the analyte sensor into subcutaneous tissue, the implant device being configured with a near field communication tag; and

[0011] a display device configured to wirelessly connect with the electronic module to display analyte data, the analyte data being obtained based on the analyte parameter, the display device comprising a near field communication module;

[0012] wherein the wireless connection between the display device and the electronic module is established through near field communication technology.

[0013] The present application adopts the above technical solutions, realizes long-time dynamic monitoring through subcutaneous implantation of the analyte sensor, covers key physiological scenes such as postprandial and exercise; the analyte parameter can be obtained in real time through the coupling connection between the electronic module and the analyte sensor; the analyte sensor can directly contact subcutaneous tissue through implantation of the analyte sensor into subcutaneous tissue by the implant device, so as to avoid measurement error caused by diffusion of body fluid and improve data reliability; the analyte data, i.e. blood glucose monitoring data, can be obtained through processing of the analyte parameter; the display device is connected based on the near field communication module and the electronic module, so as to display the blood glucose monitoring data through the display device; the display device is triggered based on touch between the near field communication tag and the display device, and wireless connection between the display device and the electronic module is realized through near field communication technology.

[0014] In an implementation manner of the present application, the near field communication module contains first connection data, the display device contains second connection data, and the display device establishes wireless communication with the electronic module based on the first connection data and the second connection data.

[0015] The present application adopts the above technical solutions, the near field communication module contains first connection data written in advance, and the electronic module which needs to be connected with the display device can be determined through the connection data; the display device contains second connection data of an application program corresponding to the analyte, and the display device can establish wireless communication connection between the display device and the electronic module based on the first connection data and the second connection data after receiving the first connection data associated with the analyte.

[0016] In an implementation manner of the present application, the display device further comprises a judgment module configured to judge whether the first connection data and the second connection data match.

[0017] The application adopts the technical solution, and a judgment module arranged in the display device is used to compare the first connection data and the second connection data, to judge whether the electronic module to be connected and the application program of the analyte in the display device are matched, and to establish wireless communication between the display device and the electronic module after confirming that the two are matched.

[0018] In an implementation manner of the application, the display device further comprises an analyte application program, and the near field communication tag comprises start instructions for starting the application program, which are transmitted to the display device through the near field communication channel to start the application program.

[0019] The application adopts the technical solution, and an analyte application program arranged in the display device is used to receive, process and display analyte data, such as a blood glucose concentration trend chart and an alarm. The start instructions of the corresponding analyte application program are stored in the near field communication tag arranged in the implanted device, so that when the display device is close to the implanted device, the near field communication tag is activated through electromagnetic induction, and then the start instructions are transmitted to the display device through the near field communication channel, to automatically trigger the start of the application program and load the related function modules in the application program, thereby simplifying the operation process, enabling the user to view the latest data in time, and improving the user experience.

[0020] In an implementation manner of the application, the start instructions comprise source information of the application program.

[0021] The application adopts the technical solution, and the source information of the application program stored in the start instructions is used to facilitate subsequent automatic starting of the corresponding application program in the display device, and display of the obtained analyte data through the display device.

[0022] In an implementation manner of the application, the analyte sensor is configured to monitor blood glucose concentration, and the electronic module is configured to transmit the analyte parameter or the analyte data to the display device through Bluetooth.

[0023] The application adopts the technical solution, and the analyte sensor is configured to monitor blood glucose concentration, to realize real-time monitoring of the change of blood glucose concentration. The electronic module directly transmits the obtained analyte parameter to the display device based on Bluetooth connection between the display device and the electronic module, and the display device subsequently processes and displays the analyte parameter. The method of directly transmitting the analyte parameter can reduce the data processing pressure of the electronic module. Alternatively, the electronic module processes the obtained analyte parameter to obtain corresponding analyte data, and then transmits the processed analyte data to the display device for display. In this way, the user can directly view the analyte data after successful data transmission, without waiting for the display device to process the analyte parameter.

[0024] In an implementation form of the implant device, the implant device comprises a housing, a drive unit arranged in the housing for driving the analyte sensor to be implanted into subcutaneous tissue, and the near field communication tag is arranged in the housing.

[0025] The above technical solution is adopted in the present application. The housing is used as the physical packaging of the implant device, which can not only avoid exposure of the analyte sensor, but also protect the internal drive unit from external mechanical damage or biological corrosion, thereby reducing the risk of infection of the user by pathogenic bacteria. The drive unit precisely implants the analyte sensor into the subcutaneous tissue through a micro mechanical structure such as a spring or an electric push rod, thereby reducing the risk of tissue tearing and reducing the pain of the patient. The near field communication tag is arranged in the housing, which facilitates the display device to trigger the near field communication connection between the electronic module based on the touch of the near field communication tag on the housing, and then triggers the data transmission, thereby shortening the operation time.

[0026] In an implementation form of the implant device, the housing comprises an upper housing and a bottom cover detachably connected with the upper housing, the drive unit is movably arranged in the upper housing, and the near field communication tag is arranged in the bottom cover.

[0027] The above technical solution is adopted in the present application. The housing is designed in a split type, the bottom cover is independently detachable, the drive unit is fixed in the upper housing, and the split housing supports independent replacement of the analyte sensor and the drive unit. The near field communication tag is arranged on the bottom cover, which facilitates the touch of the display device to trigger the connection of the near field communication module. When the analyte sensor is implanted into the subcutaneous tissue by the drive unit, the bottom cover detachably connected with the upper housing is first opened, and then the upper housing is fixed on the skin surface, and then the sensor is pushed into the subcutaneous tissue by the drive unit.

[0028] In an implementation form of the implant device, the first connection data comprises a channel code, a life code of the analyte sensor, and a unique link code.

[0029] The above technical solution is adopted in the present application. The first connection data comprises a channel code, a life code of the analyte sensor, and a unique link code. The channel code and the life code are derived from the order information of the analyte sensor, and the unique link code is derived from the material information of the analyte sensor. Through the triple authentication mechanism of the channel code, the life code and the unique link code, the integrated management of device traceability, life monitoring and accurate pairing is realized.

[0030] In an implementation form of the system, the system further comprises a near field communication tag verification module, the near field communication tag verification module comprises turnover information, and the near field communication tag verification module verifies the correspondence between the first connection data and the electronic module based on the turnover information.

[0031] The application adopts the technical scheme, and by embedding the turnover information in the near field communication tag checking module, the correspondence between the first connection data in the near field communication tag and the electronic module is checked according to the turnover information, so as to determine whether the first connection data written in the near field communication tag is correct. BRIEF DESCRIPTION OF DRAWINGS

[0032] The accompanying drawings, which are included to provide a further understanding of the application and are incorporated in and constitute a part of this application, illustrate embodiments of the application and serve to explain the principles of the application. In the drawings:

[0033] Figure 1 A schematic diagram of a continuous analyte monitoring system architecture is provided for the embodiments of the application;

[0034] Figure 2 A schematic diagram of the structure of an upper shell, an electronic module and a bottom cover of a continuous analyte monitoring system is provided for the embodiments of the application;

[0035] Figure 3 A schematic diagram of a near field communication tag is provided for the embodiments of the application.

[0036] Reference signs:

[0037] 1, upper shell; 2, electronic module; 3, bottom cover. DETAILED DESCRIPTION

[0038] In order to make the purpose, technical scheme and advantages of the application clearer, the technical scheme of the application will be described clearly and completely below in combination with the specific embodiments of the application and the corresponding drawings. Obviously, the described embodiments are only some of the embodiments of the application, not all the embodiments. Based on the embodiments in the application, all other embodiments obtained by those skilled in the art without creative labor fall within the scope of protection of the application.

[0039] The technical scheme provided by each embodiment of the application will be described in detail below in combination with the drawings.

[0040] Figure 1 A schematic diagram of the architecture of a continuous analyte monitoring system is provided for the embodiments of the application. As shown in Figure 1 The application discloses a continuous analyte monitoring system, which includes an analyte sensor, an electronic module, an implant device Figure 1 (not shown), a display device and a near field communication tag.

[0041] The analyte sensor is implanted into the subcutaneous tissue to obtain the analyte parameter in real time, and dynamic monitoring of the analyte parameter is realized. The electronic module is coupled to the analyte sensor, and the electronic module can obtain the analyte parameter collected by the analyte sensor in real time based on the coupling. The analyte sensor is implanted into the subcutaneous tissue by the implanting device, so that the analyte sensor can directly contact the subcutaneous tissue, and the data reliability is improved. The analyte data received by the electronic module is displayed by the display device. It should be noted that the analyte data in the embodiment of the application is obtained by processing the analyte parameter obtained by the analyte sensor. In addition, the display device also includes a near field communication module, and the display device can realize wireless connection with the electronic module based on the near field communication module.

[0042] In one embodiment, the near field communication tag is an NFC tag.

[0043] In one embodiment, the near field communication module contains pre-written first connection data, and the first connection data is used to determine the electronic module that needs to be connected with the display device. The display device contains second connection data of the application program corresponding to the analyte. The display device determines the connection parties through the first connection data and the second connection data, so as to establish the wireless communication connection between the display device and the electronic module.

[0044] It should be noted that the writing process of the first connection data in the near field communication module includes: setting the display device and the implanting device within a predetermined near field communication distance range, activating the near field communication tag in the implanting device by electromagnetic induction of the display device, obtaining the first connection data stored in the near field communication tag and writing it into the near field communication module.

[0045] In one embodiment, a two-dimensional code tag is formed based on the first connection data, and the two-dimensional code tag is arranged on the implanting device. In addition to obtaining the first connection data through the near field communication tag, the display device can also obtain the first connection data by scanning the two-dimensional code tag, and then establish the wireless communication connection between the display device and the electronic module based on the first connection data and the second connection data.

[0046] In one embodiment, the second connection data in the display device is derived from the electronic module. Specifically, the display device receives and stores the second connection data sent by the electronic module through Bluetooth technology, and then establishes the wireless communication connection with the electronic module based on the first connection data and the second connection data.

[0047] In one embodiment, the display device further includes a judging module. The first connection data and the second connection data are compared by the judging module to confirm whether the electronic module and the application program of the analyte in the display device are matched, so that the wireless communication between the display device and the electronic module is established when they are matched.

[0048] Specifically, the display device determines whether the first connection data and the second connection data are the same through the judging module, and confirms that the electronic module matches the application program of the analyte in the display device in the case of being the same, so as to establish the wireless communication between the display device and the electronic module.

[0049] In one embodiment, the analyte application program is installed in the display device, and the analyte data can be received, processed and displayed through the application program. The start instruction corresponding to the analyte application program is stored in the near field communication tag, so that when the display device contacts the near field communication tag in the implanted device, the near field communication tag is activated through electromagnetic induction, and the application program start instruction pre-stored in the near field communication tag is transmitted to the display device. The display device automatically starts the corresponding application program based on the application program start instruction, and loads the function module corresponding to the analyte sensor in the application program, so as to be displayed on the display device, which is convenient for the user to view the analyte data.

[0050] In one embodiment, the start instruction contains the source information of the above-mentioned application program, and the display device can determine the application program to be started through the source information, and automatically start the corresponding application program according to the start instruction. The display device displays the analyte data obtained through the electronic module on the corresponding function module of the application program.

[0051] In one embodiment, when the display device contacts the near field communication tag in the implanted device, the near field communication tag can be activated through electromagnetic induction to obtain the first connection data and the application program start instruction stored in the near field communication tag at the same time, and the corresponding analyte application program is automatically started when the display device establishes wireless communication with the electronic module, thereby reducing the operation steps of the user, avoiding the possibility of manual operation error, and improving the user experience.

[0052] In one embodiment, the analyte sensor is configured as a sensor for detecting blood glucose concentration, realizing real-time monitoring of the change of blood glucose concentration. By configuring the electronic module to connect with the display device based on Bluetooth, the analyte parameters are directly transmitted to the display device through Bluetooth connection, or the analyte parameters are first processed on the electronic module to obtain the corresponding analyte data, and then the analyte data is transmitted to the display device. It should be noted that directly transmitting the analyte parameters to the display device can reduce the data processing pressure of the electronic module; and processing the analyte parameters and transmitting the analyte data to the display device enables the user to directly display the data after the display device successfully receives the data, without the user waiting for the display device to process the analyte parameters.

[0053] In one embodiment, the implant device of the present application comprises a housing and a driving unit arranged in the housing, the housing serves as the physical package of the implant device, which can avoid the exposure of the analyte sensor and the internal driving unit from external mechanical damage or biological corrosion, thereby reducing the risk of infection of the user by pathogenic bacteria. It should be noted that in the embodiment of the present application, the driving unit is arranged in the upper shell of the housing, and the near field communication tag is arranged in the housing. The driving unit precisely implants the analyte sensor into the subcutaneous tissue through a micro mechanical structure such as a spring or an electric push rod, which reduces the risk of tissue tearing and reduces the pain of the patient. By arranging the near field communication tag on the housing, the display device can trigger the near field communication connection between the electronic module based on the touch of the near field communication tag on the housing, and then trigger the data transmission, thereby shortening the operation time.

[0054] In one embodiment, the housing adopts a split design, including an upper shell and a bottom cover detachably connected with the upper shell, the driving unit is fixed in the upper shell, and the split housing supports independent replacement of the analyte sensor and the driving unit. The near field communication tag is arranged on the bottom cover, which is convenient for triggering the near field communication module connection by touching the display device. When the analyte sensor is implanted into the subcutaneous tissue by the driving unit, the bottom cover detachably connected with the upper shell is first opened, and then the upper shell is fixed on the skin surface, and then the sensor is pushed into the subcutaneous tissue by the driving unit.

[0055] Figure 2 The structure diagram of the upper shell, the electronic module and the bottom cover of the continuous analyte monitoring system provided by the embodiment of the present application is shown in Figure 2 As shown in the figure, the upper shell 1, the analyte sensor 2, the detachably connected bottom cover 3 and the driving unit jointly constitute a split design housing, the bottom cover 3 can be independently detached, which is used to protect the driving unit in the upper shell and the analyte sensor 2 in a sealed state, which is not polluted by the outside world, thereby reducing the risk of infection of the user.

[0056] It should be noted that the driving unit in the embodiment of the present application is a spring structure, the spring releases elastic potential energy, and under the action of the spring, the analyte sensor moves downward, so that the analyte sensor moves downward and penetrates into the subcutaneous tissue.

[0057] In one embodiment, the display device can be a mobile terminal such as a mobile phone or a tablet computer.

[0058] Figure 3 The schematic diagram of the near field communication tag provided by the embodiment of the present application is shown in Figure 3As shown, the application is provided with an NFC tag on the bottom cover 3 detachably connected with the upper shell, facilitating the user to trigger the NFC tag through the display device. It should be noted that the application sets the NFC tag on the bottom cover, so that the area of the NFC tag is larger, and the user can trigger it by placing the display device within the range of the NFC tag, without the need for very accurate alignment. The operation is intuitive and convenient, and the user experience is better.

[0059] In one embodiment, the first connection data includes a channel code, a life code of the analyte sensor, and a unique link code. The channel code and the life code are derived from the order information of the analyte sensor, and the unique link code is derived from the material information of the analyte sensor, i.e. the first connection data is processed based on the order information and the material information of the analyte sensor. Through the triple authentication mechanism of the channel code, the life code and the unique link code, the integrated management of device traceability, life monitoring and precise pairing is realized.

[0060] In one embodiment, the display device compares the unique link code in the first connection data with the second connection data through the judgment module to confirm whether the application program of the analyte in the electronic module and the display device matches, so as to establish wireless communication between the display device and the electronic module in the case of matching.

[0061] Specifically, the display device determines whether the unique link code in the first connection data and the second connection data are the same through the judgment module, and confirms that the application program of the analyte in the electronic module and the display device matches in the case of being the same, so as to establish wireless communication between the display device and the electronic module.

[0062] In one embodiment, the continuous analyte monitoring system in the application further includes a near field communication tag verification module and a data server. The turnover information of the analyte sensor is built-in in the near field communication tag verification module, which is used to associate the order information, the material information and the connection information corresponding to the analyte sensor in the data server, and the connection information includes the first connection data. The connection information corresponding to the turnover information can be obtained by searching in the data server according to the turnover information in the near field communication tag verification module, and the connection information stored in the near field communication tag is obtained. By comparing the connection information corresponding to the turnover information with the connection information stored in the near field communication tag, it can be determined whether the first connection data written in the near field communication tag is correct, and the connection information in the tag is ensured to be correct through tag verification. If the first connection data written in the near field communication tag is correct, the subsequent wireless connection establishment step is entered, and if the first connection data written in the near field communication tag is incorrect, an alarm signal is output to prompt the staff to replace or correct.

[0063] The places not mentioned in the application can be realized by adopting or referring to the existing technology.

[0064] The various embodiments in the specification are described in progressive manner, and the same or similar parts between the various embodiments can be mutually referred to, and each embodiment focuses on the difference from other embodiments.

[0065] The above only describes the embodiments of the present application and is not intended to limit the present application. The present application can have various changes and modifications for those skilled in the art. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the scope of claims of the present application.

Claims

1. A continuous analyte monitoring system, characterized in that, The system comprises: an analyte sensor configured to obtain an analyte parameter; an electronic module coupled to the analyte sensor to obtain the analyte parameter; an implant device configured to implant the analyte sensor into subcutaneous tissue, the implant device being provided with a near field communication tag; and a display device configured to wirelessly connect to the electronic module to display analyte data based on the analyte parameter, the display device comprising a near field communication module; wherein the display device and the electronic module establish wireless connection through near field communication technology. The near field communication module comprises first connection data, the display device comprises second connection data, and the display device establishes wireless communication with the electronic module based on the first connection data and the second connection data.

2. The continuous analyte monitoring system of claim 1, wherein, The display device further comprises a judgment module configured to judge whether the first connection data and the second connection data match.

3. The continuous analyte monitoring system of claim 2, wherein, The display device further comprises an analyte application program, and the near field communication tag comprises a start instruction for starting the application program, the start instruction being transmitted to the display device through a near field communication channel to start the application program.

4. The continuous analyte monitoring system of claim 1, wherein, The start instruction comprises source information of the application program.

5. The continuous analyte monitoring system of claim 4, wherein, The analyte sensor is configured to monitor blood glucose concentration, and the electronic module is configured to transmit the analyte parameter or the analyte data to the display device through Bluetooth.

6. The continuous analyte monitoring system of claim 1, wherein, The implant device comprises a housing, a driving unit arranged in the housing and configured to drive the analyte sensor to implant into subcutaneous tissue, and the near field communication tag is arranged in the housing.

7. The continuous analyte monitoring system of claim 1, wherein, The housing comprises an upper housing and a bottom cover detachably connected to the upper housing, the driving unit is movably arranged in the upper housing, and the near field communication tag is arranged in the bottom cover.

8. The continuous analyte monitoring system of claim 7, wherein, The first connection data comprises a channel code, a life code of the analyte sensor, and a unique link code.

9. The continuous analyte monitoring system of claim 2, wherein, The system further comprises a near field communication tag verification module, the near field communication tag verification module comprises turnover information, and the near field communication tag verification module verifies the correspondence between the first connection data and the electronic module based on the turnover information.

10. The continuous analyte monitoring system of claim 2, wherein, ​

Images